Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026)

Cerus' (CERS) quarterly Liabilities and Shareholders Equity came in at $205.2 million in Q2 2026, down 3.7% year-over-year from $213.1 million in Q2 2025, and down 7.95% quarter-over-quarter from $222.9 million in Q1 2026.

Analysis

Cerus (CERS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Cerus has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $205.2 million for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity fell 3.7% year-over-year to $205.2 million; the TTM figure through Jun 2026 stood at $865.1 million (up 6.77% YoY), while the FY2025 annual figure was $221.9 million, up 10.42% from the prior year.
  • Liabilities and Shareholders Equity came in at $205.2 million for Q2 2026 at Cerus, down from $222.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $222.9 million in Q1 2026 to a low of $185.5 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $207.4 million, with a median of $208.1 million recorded in 2023.
  • Year-over-year, Liabilities and Shareholders Equity slipped 9.65% in 2024 and climbed 14.87% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $218.1 million in 2022, then retreated by 9.33% to $197.7 million in 2023, then advanced by 1.6% to $200.9 million in 2024, then rose by 10.42% to $221.9 million in 2025, then declined by 7.51% to $205.2 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $205.2 million in Q2 2026, $222.9 million in Q1 2026, and $221.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 20.88 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 93.31 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 13.87 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 31.10 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 6.46 Bn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 10.74 Bn
10 Cerus 521.95 Mn 466.38 Mn 29.53 Mn 205.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 205.19 Mn
Mar 31, 2026 222.91 Mn
Dec 31, 2025 221.86 Mn
Sep 30, 2025 215.19 Mn
Jun 30, 2025 213.07 Mn
Mar 31, 2025 206.78 Mn
Dec 31, 2024 200.92 Mn
Sep 30, 2024 189.54 Mn
Jun 30, 2024 185.50 Mn
Mar 31, 2024 189.14 Mn
Dec 31, 2023 197.75 Mn
Sep 30, 2023 205.84 Mn
Jun 30, 2023 198.86 Mn
Mar 31, 2023 209.34 Mn
Dec 31, 2022 218.09 Mn
Sep 30, 2022 215.40 Mn
Jun 30, 2022 216.46 Mn
Mar 31, 2022 221.91 Mn
Dec 31, 2021 237.50 Mn
Sep 30, 2021 218.95 Mn